32.jpg)
56.jpg)
USE OF LAUREQUINONE AS AN ANTIPARASITIC AGENT
Patent number:
P202030582
No items found.
The invention discloses the use of the compound Laurequinone, in particular as a drug for human or veterinary use, and more particularly in the field of parasitic diseases. Furthermore, the present invention relates to methods for obtaining said compound. Laurequinone presented good activity against promastigotes of Leishmania amazonensis, showing low mean inhibitory concentration (CI50) and low mean cytotoxic concentration (CC50) values.
Countries:
Spain
Regions:
Canary Islands
Centers:
UNIVERSIDAD DE LA LAGUNA
Other entities:
Universidad Autónoma de Nuevo León (UANL)
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
SDG03: Good health and well-being
Applications
Use in the treatment of Leishmaniasis. Better selectivity than other conventional treatments such as Miltefosine.
Comments
Other related patents
Health
Faecal microbiota signature for pancreatic cancer
New & Sustainable Materials
Other
Health
Aerospace
Automotive & Rail
Manufacturing method of an electronic device comprising a non-flat laminar item with a non-flat electronic circuit thereon
Health